Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Background Agonistic anti-CD40 monoclonal antibodies (mAbs) have emerged as promising immunotherapeutic compounds with impressive antitumor effects in mouse models. However, preclinical and clinical studies faced dose-limiting toxicities mediated by necroinflammatory liver disease. An effective prop...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Florence Vallelian, Marc Pfefferlé, Irina L Dubach, Raphael M Buzzi, Elena Dürst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy, Thierry Roger, Rok Humar, Dominik J Schaer
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMJ Publishing Group 2023-01-01
Serie:	Journal for ImmunoTherapy of Cancer
Länkar:	https://jitc.bmj.com/content/11/1/e005718.full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!